Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions

OBJECTIVES: Although biomarkers predicting therapy response in first‐line metastatic renal carcinoma (mRCC) therapy remain to be defined, C‐reactive protein (CRP) kinetics have recently been associated with immunotherapy (IO) response. Here, we aimed to assess the predictive and prognostic power of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeh, Benedikt, Garcia, Cristina Cano, Banek, Severine, Klümper, Niklas, Cox, Alexander, Ellinger, Jörg, Schmucker, Philipp, Hahn, Oliver, Mattigk, Angelika, Zengerling, Friedemann, Becker, Philippe, Erdmann, Kati, Buerk, Bjoern Thorben, Flegar, Luka, Huber, Johannes, Kalogirou, Charis, Zeuschner, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600333/
https://www.ncbi.nlm.nih.gov/pubmed/37899949
http://dx.doi.org/10.1002/cti2.1471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600333/
https://www.ncbi.nlm.nih.gov/pubmed/37899949
http://dx.doi.org/10.1002/cti2.1471

Ejemplares similares